1. Home
  2. GENC vs NKTR Comparison

GENC vs NKTR Comparison

Compare GENC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GENC
  • NKTR
  • Stock Information
  • Founded
  • GENC 1894
  • NKTR 1990
  • Country
  • GENC United States
  • NKTR United States
  • Employees
  • GENC N/A
  • NKTR N/A
  • Industry
  • GENC Construction/Ag Equipment/Trucks
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GENC Industrials
  • NKTR Health Care
  • Exchange
  • GENC Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • GENC 181.9M
  • NKTR 160.4M
  • IPO Year
  • GENC N/A
  • NKTR 1994
  • Fundamental
  • Price
  • GENC $11.54
  • NKTR $0.64
  • Analyst Decision
  • GENC
  • NKTR Strong Buy
  • Analyst Count
  • GENC 0
  • NKTR 6
  • Target Price
  • GENC N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • GENC 32.1K
  • NKTR 2.8M
  • Earning Date
  • GENC 05-09-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • GENC N/A
  • NKTR N/A
  • EPS Growth
  • GENC 35.02
  • NKTR N/A
  • EPS
  • GENC 1.11
  • NKTR N/A
  • Revenue
  • GENC $113,116,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • GENC N/A
  • NKTR N/A
  • Revenue Next Year
  • GENC N/A
  • NKTR N/A
  • P/E Ratio
  • GENC $10.44
  • NKTR N/A
  • Revenue Growth
  • GENC 5.44
  • NKTR 9.21
  • 52 Week Low
  • GENC $10.80
  • NKTR $0.43
  • 52 Week High
  • GENC $24.88
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • GENC 43.40
  • NKTR 45.85
  • Support Level
  • GENC $11.12
  • NKTR $0.43
  • Resistance Level
  • GENC $11.97
  • NKTR $0.68
  • Average True Range (ATR)
  • GENC 0.65
  • NKTR 0.08
  • MACD
  • GENC -0.00
  • NKTR 0.01
  • Stochastic Oscillator
  • GENC 50.34
  • NKTR 72.41

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: